If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

Tom Freeman is the Director of the Addiction and Mental Health Group (AIM), an interdisciplinary research group bridging the departments of Psychology and Life Sciences at the University of Bath. He is an elected Trustee and Director of the Society for the Study of Addiction, and Senior Editor for the journal Addiction. He conducts commissioned projects for the European Union drugs agency and has given expert evidence for the National Institute of Health and Care Excellence (NICE) and the Advisory Council on the Misuse of Drugs (ACMD).

Tom is internationally known for his research on cannabis and cannabinoids. His work includes: observational studies characterising changes in cannabis products and their association with addiction and mental health outcomes; novel harm reduction strategies such as the standard THC unit (similar to the standard alcohol unit), the potential of cannabidiol to influence the effects of cannabis, and clinical trials of cannabidiol as a treatment for cannabis use disorder.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being
  • SDG 10 - Reduced Inequalities


Dive into the research topics where Tom Freeman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles


Recent external collaboration on country/territory level. Dive into details by clicking on the dots or